Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221955 · ClinicalTrials.gov registry record · NA
The Impact of Qualia Gluthathione+ on Blood Glutathione Levels
A NA study, sponsored by Qualia Life Sciences.
- Not yet
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT07221955 is a NA study that has not yet begun recruiting, run by Qualia Life Sciences. The registered enrollment target is 54 participants.
The verdict
NCT07221955, a NA study, has not yet begun recruiting, sponsored by Qualia Life Sciences.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, parallel-group, triple-armed, study evaluating the effects of two distinct Qualia Glutathione+ formulations on Whole Blood Glutathione levels in the blood of healthy adults aged 45-75 years. Approximately 18 participants will be randomized to one of three study arms: Qualia Glutathione+ version 1, Qualia Glutathione+ version 2, or placebo. Each participant will take two or three capsules of their assigned product once daily in the morning, with or without food, over a 20-day period. The primary outcome is the change in blood glutathione levels, assessed via in lab blood collection at baseline and study completion. Secondary endpoints include questionnaires measuring health-related quality of life, fatigue, and cognitive functioning (PROMIS Global Health-10, PROMIS Short Form v1.0 - Fatigue 10a, PROMIS Cognitive Function - Short Form 8a), evaluation of safety and tolerability, and an Overall Experience Questionnaire (Appendices 1, 4-7). All assessments, including electronic questionnaires, are completed remotely without in-person visits.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Qualia Glutathione+ version 1
- DIETARY_SUPPLEMENT Qualia Glutathione+ version 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2025-12-02 |
| Est. Completion | 2026-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07221955
The ClinicalTrials.gov registry entry for NCT07221955 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qualia Life Sciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07221955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07221955 about?
NCT07221955 is a clinical study titled "The Impact of Qualia Gluthathione+ on Blood Glutathione Levels". This is a randomized, double-blind, placebo-controlled, parallel-group, triple-armed, study evaluating the effects of two distinct Qualia Glutathione+ formulations on Whole Blood Glutathione levels in the blood of healthy adults aged 45-75 years. Approximately 18 participants will be randomized to o...
What is the current status of trial NCT07221955?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2025-12-02. Estimated completion is 2026-01-25.
What interventions are being tested in trial NCT07221955?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Qualia Glutathione+ version 1 (DIETARY_SUPPLEMENT), Qualia Glutathione+ version 2 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07221955?
This trial is sponsored by Qualia Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.